​Contents Local COVID-19 vaccines policy Technical Standard Operating Procedures (SOP) Oversight of vaccine processes by senior pharmacists Confirming readiness to receive COVID-19 vaccines The professional expectations Hospital hubs Vaccination centres Annex A: Model NHS COVID-19 Vaccine handling and management policy 2020/21 Appendix 1: Links to relevant National Standards Appendix 2: NHS Trust hospital hub & […]

Contents Table 1: General Table 2: PPE, ventilation and management of the environment Table 3: Setting specific secondary care (paediatrics/maternity/haematology etc.) Table 4: Primary care Table 5: Care homes and social care Table 6: Community settings and home care Table 7: Ambulance service and first responders Table 8: Dentistry and optometry Table 9: Letters and […]

Contents Important and urgent – next steps on NHS response to COVID-19 Free-up the maximum possible inpatient and critical care capacity Prepare for, and respond to, large numbers of inpatients requiring respiratory support Support our staff and maximise staff availability Support the wider population measures newly announced by Government Stress-test your operational readiness Remove routine […]

Classification: Official Publication approval reference: 011559 / C0943 To: All NHS primary care contractors (medical, dental, optometry and pharmacy) CC: Clinical commissioning groups (accountable officers) Regional directors/RDRCPCH Regional heads of primary care 16 December 2020 Dear colleagues On 9 November we announced that the Government had agreed that testing will be made available to all […]

Contents Legal basis and expectations of HMR regulation 174 (temporary) authorisation for supply of the vaccine products Supporting GPs in delivering this important role Local Covid-19 vaccines policy Technical Standard Operating Procedures (SOP) Oversight and support of vaccine processes by senior pharmacists Annex A: Model NHS COVID-19 Primary Care Vaccine handling and management policy 2020-21 […]

Classification: Official Publication approval reference: 001599 / C1009 To: All general practices in England Cc: Regional Directors of Public Health and Primary Care CCG Accountable Officers and Clinical Leads CCG Chief Pharmacists/Heads of Medicines Optimisation Regional Chief Pharmacists 7 January 2021 Dear Colleague, Further to the temporary Authorisation of the COVID-19 Vaccine Oxford AstraZeneca (“AZ […]

Contents Equalities and health inequalities statement Introduction Commonly used terms 1 Agreement between the parties 2 Service description and background 3 Aims and intended outcomes 4 Patient JCVI Cohorts and priority groups 5 Eligibility of patients 6 Patient recruitment 7 Assessment and consent 8 Vaccine administration 9 Vaccine handling and storage 10 Record keeping 11 […]

Contents Pfizer/BioNTech COVID-19 mRNA Vaccine BNT 162b2 Other COVID-19 vaccinations Legal basis and expectations of the different routes to authorisation for supply of the vaccine products Supporting pharmacy staff in delivering this important role Accountability for community pharmacy-led COVID-19 local vaccination services Role of the Responsible Pharmacist Supervising Pharmacist Technical Standard Operating Procedures (SOP) Advice […]

Contents COVID-19 Vaccine Oxford/AstraZeneca Technical Standard Operating Procedures (SOP) Vaccination of frontline healthcare staff   Classification: Official Publications approval reference: 001559 / C1021 To: Lead Responsible NHS Trust hospital chief pharmacists Lead Responsible CCG Chief Pharmacists/Heads of Medicines Optimisation Cc: All NHS Trust hospital chief pharmacists All CCG Chief Pharmacists/Heads of Medicines Optimisation NHS Trust […]

Contents Summary COVID-19 additional revenue expenditure reporting COVID-19 revised capital reimbursement claim process Annex 1: Guidance on 2020/21 COVID-19 revenue cost reporting (second phase) Table 1: COVID-19 policies, directives or nationally approved business cases Table 2: Consequences of COVID-19 Table 3: Costs of nationally procured items/services Annex 2: Submission and approval process for capital expenditure […]